|
Volumn 25, Issue 5, 2001, Pages 344-348
|
The role of MRI in the intestinal complications in cystic fibrosis
|
Author keywords
Cystic fibrosis; MRI
|
Indexed keywords
BIOLOGICAL ORGANS;
DISEASES;
ENZYMES;
PATIENT TREATMENT;
FAT-SUPPRESSION;
MAGNETIC RESONANCE IMAGING;
CONTRAST MEDIUM;
FERUMOXSIL;
GADOLINIUM PENTETATE;
PANCREAS ENZYME;
ADOLESCENT;
ADULT;
ARTICLE;
ASCENDING COLON;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COLON DISEASE;
CONTRAST ENHANCEMENT;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYSTIC FIBROSIS;
DEVICE;
DIAGNOSTIC IMAGING;
DIAGNOSTIC VALUE;
DRUG MEGADOSE;
EDEMA;
ENZYME THERAPY;
FECES IMPACTION;
FEMALE;
FIBROSIS;
HUMAN;
ILEUM;
INTESTINE WALL;
MALE;
NON INVASIVE MEASUREMENT;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PANCREAS INSUFFICIENCY;
SCHOOL CHILD;
TECHNIQUE;
ADOLESCENT;
ADULT;
CHILD;
CONTRAST MEDIA;
CYSTIC FIBROSIS;
ENZYMES;
EXOCRINE PANCREATIC INSUFFICIENCY;
FEMALE;
GADOLINIUM DTPA;
HUMANS;
INTESTINAL DISEASES;
MAGNETIC RESONANCE IMAGING;
MALE;
|
EID: 0034776993
PISSN: 08997071
EISSN: None
Source Type: Journal
DOI: 10.1016/S0899-7071(01)00326-6 Document Type: Article |
Times cited : (7)
|
References (27)
|